Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
8,502.00
-18.6 (-0.22%)
BSENSE

Jun 18

BSE+NSE Vol: 2.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAstrazeneca Phar VS Pharmaceuticals & Biotechnology
 
1D
-0.22%
0.33%
1W
3.07%
4.85%
1M
0%
2.78%
YTD
-5.64%
-9.17%
1Y
-12.66%
-4.95%
3Y
133.5%
22.13%
5Y
130.45%
47.89%
10Y
676.26%
190.73%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.37%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.07%
0%
0.07%
6 Months
-6.31%
0%
-6.31%
1 Year
-12.66%
0.36%
-12.3%
2 Years
32.11%
0.90%
33.01%
3 Years
133.5%
1.92%
135.42%
4 Years
209.73%
2.43%
212.16%
5 Years
130.45%
2.31%
132.76%

Latest dividend: 32 per share ex-dividend date: Jul-18-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
10.16%
3
Quartile
quartile-3
Dec-Mar
-13.88%
3
Quartile
quartile-3
Sep-Dec
-1.18%
3
Quartile
quartile-3
YTD
-12.19%
1
Quartile
quartile-1
2025
22.84%
4
Quartile
quartile-4
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
10.16%
2
Quartile
quartile-2
Dec-Mar
-13.88%
2
Quartile
quartile-2
Sep-Dec
-1.18%
3
Quartile
quartile-3
YTD
-12.19%
1
Quartile
quartile-1
2025
22.84%
3
Quartile
quartile-3
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
10.16%
2
Quartile
quartile-2
Dec-Mar
-13.88%
2
Quartile
quartile-2
Sep-Dec
-1.18%
3
Quartile
quartile-3
YTD
-12.19%
1
Quartile
quartile-1
2025
22.84%
2
Quartile
quartile-2
2024
32.88%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available